Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Solveig, Hafsteinsdottir"'
Autor:
Anna, Østergaard, Cathrine, Bohnstedt, Kathrine, Grell, Matilda, Degn, Bernward, Zeller, Mervi, Taskinen, Solveig, Hafsteinsdottir, Helga, Björgvinsdóttir, Mats, Heyman, Peter, Hoogerbrugge, Kjeld, Schmiegelow
Publikováno v:
Leukemia. 35(3)
Autor:
Arja Harila-Saari, Thomas Frandsen, Outi Mäkitie, Kjeld Schmiegelow, Kadri Saks, Nina Toft, Anne Vestli, Signe Sloth Mogensen, Ida Hed Myrberg, Louise Rold Helt, Riitta Niinimäki, Laimonas Griskevicius, Jens Retpen, Solveig Hafsteinsdottir, Helene Hallböök
Publikováno v:
Pediatric Blood & Cancer. 65:e27300
BACKGROUND Treatment-related osteonecrosis (ON) is a serious complication of treatment of acute lymphoblastic leukemia (ALL). PROCEDURE This study included 1,489 patients with ALL, aged 1-45 years, treated according to the Nordic Society of Paediatri
Autor:
Kristinsson, Ásgeir Haraldsson, Gudmundur K. Jonmundsson, Jacek Winiarski, Jan-Inge Henter, Solveig Hafsteinsdottir
Publikováno v:
Acta Paediatrica. 91:974-977
UNLABELLED Familial haemophagocytic lymphohistiocytosis (FHL) is a rare, autosomal recessive disease of infancy and early childhood clinically characterized by fever, hepatosplenomegaly, lymphadenopathy, rash, neurological symptoms and icterus. Commo
Autor:
Kjeld Schmiegelow, Bernward Zeller, Susanne Rosthøj, Mogens T. Levinsen, Solveig Hafsteinsdottir, Mervi Taskinen, Cathrine Bohnstedt, Mats Heyman, Helga Björgvinsdóttir
Publikováno v:
Leukemia. 27(4)
Abstract 2577 Children with Down syndrome (DS) and acute lymphoblastic leukemia (ALL) have an inferior prognosis compared to non-DS ALL patients. We reviewed Methotrexate (MTX)/Mercaptopurine (6MP) maintenance therapy data for children with DS treate
Autor:
Kjeld Schmiegelow, Helga Björgvinsdóttir, Catherine Bohnstedt, Bernward Zeller, Solveig Hafsteinsdottir, Mervi Taskinen
Publikováno v:
Journal of Pediatric Hematology/Oncology. 31:79-80